ChristopherGeraldCannMD

Gastrointestinal Cancer

Assistant Professor

Dr. Cann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
Vanderbilt University Medical CenterResidency, Internal Medicine, 2017 - 2020
Lewis Katz School of Medicine at Temple UniversityClass of 2017

PubMed

Transverse colon cancer: a call for focused research in an understudied heterogenous disease.
Christopher Cann, Efrat Dotan
Journal of Gastrointestinal Oncology. 2024-08-31
Colorectal cancer.
Cathy Eng, Takayuki Yoshino, Erika Ruíz-García, Nermeen Mostafa, Christopher G Cann
Lancet. 2024-07-20
Mutational Signature Changes in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.
Michael LaPelusa, Christopher Cann, Kristen K Ciombor, Cathy Eng
The Oncologist. 2024-04-04

Journal Articles

Blood-based surveillance monitoring of circulating tumor DNA from patients with small cell lung cancer detects disease relapse and predicts death in patients with limi...
Wade T. Iams, Prasad R. Kopparapu, Yingjun Yan, Anel Muterspaugh, Zhiguo Zhao, Heidi Chen, Christopher Cann, Sally York, Leora Horn, Kristen Ancell, Kenneth Wyman, Cat..., JTO Clinical and Research Reports, 3/12/2020

The Doctors Bringing a&E to Your HomeFebruary 16th, 2023
Cancer Rates in People Younger Than 50 Are Rising, New Study Finds. Doctors Don't yet Know WhyAugust 17th, 2023
Cancer Rates Rising in Under-50s, but Doctors Don’t Know WhyAugust 20th, 2023
Join now to see all